eso course on 26-28 may 2020 pathology of tuzla … · 2019. 10. 30. · courses and seminars 26-28...

COURSES AND SEMINARS

26-28 May 2020 TuzlaBosnia and herzegovina

Chairs:

E. Iljazović, BH - V. Kesić, RS

ESO COURSE ONPAThOLOGy Of

GyNAECOLOGICAL TUMOURS

The course is endorsed by

Gynae Tuzla (28 Oct)_Layout 1 28.10.2019 11:48 Pagina 3

INTRODUCTIONThe course on gynaecological tumours has been designed for pathologists, gynecological oncologists and medical oncologists of the Eastern Europe and Balkan Region, with the aim toprovide an update on the State of-the art diagnostics as well as an overview of the latest advances in the field of pathology.

The programme will offer educational lectures covering updates on the diagnosis and treatment of both early and advanced gynaecological cancers. Moreover, spotlight lectureswill cover specific issues related to particular situations such as diagnostic dillemas in mostchallenging cases. Biological potential, questionable invasion or type of tumor as well as gynaecological cancer in young or pregnant women will be discussed.

Practical training will be offered in the frame of „tips and tricks“ sessions in a mode of case presentations, prepared and presented by participants and discussed with the faculty.

LEARNING OBJECTIVES• Update on the latest advances in diagnostic procedures• Improve practical skills in solving diagnostic dilemas/problems and setting the best

diagnosis for gynaecological cancer patients • Update on the latest advances and on the state-of- the-art treatment options• Debate on controversies and challenges in gynaecological cancer diagnostics and treatment• Learn about the management of specific situations

MAIN TOPCIS• Gyneacological cancer pathology• Update on standard and new diagnostic and treatment options for gynecological cancer• Patohistological diagnosis and treatment of gynaecological cancer - closer than ever

CME ACCREDITATION AND CERTIfICATEThe course has been accredited by the European Accreditation Council for Continuing MedicalEducation (EACCME) to provide the following CME activity for medical specialists. TheEACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net.The programme has been granted 9 European CME credits (ECMEC). Each medical specialistshould claim only those hours of credit that he/she actually spent in the educational activity. Through an agreement between the European Union of Medical Specialists and the AmericanMedical Association, physicians may convert EACCME credits to an equivalent number of AMAPRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA creditcan be found at www.ama-assn.org/go/internationalcme.Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME forECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as definedby the Maintenance of Certification Program of The Royal College of Physicians and Surgeonsof Canada.Participants will receive their certificate of attendance via e-mail after the event on completionof the evaluation form.


fACULTy

S. Carinelli, European Institute of Oncology, Milan, IT

X. Matias-Guiu, Oncological Pathology, Lleida, IRBLleida, ES

E. Iljazović, University Clinical Center Tuzla, Tuzla, BH

V. Kesić, University of Belgrade, Medical School, Clinic for Obstetrics and Gynecology,

Clinical Center of Serbia, Belgrade, RS

S. Lax, Pathology Institute, LKH Graz Süd-West, Graz, AT

S. Milenković, Institute for Pathology, Clinic for Obstetrics and Gynecology,

Clinical Center of Serbia, Belgrade, RS

f. Peccatori, European School of Oncology, Milan, IT and Bellinzona, CH and European

Institute of Oncology, Milan, IT

C. Sessa, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, CH

S. Tomić, Clinical Institute of Pathology KBC Split, Split, HR


PROGRAMME

Tuesday, 26 May

18:00 Registration 19:30 Welcome dinner

Wednesday, 27 May

7:45 Registration 8:15 Welcome address and general introduction

CERVICAL CANCER

9:00 Diagnosis of microinvasive cervical cancer • Challenge for colposcopist V. Kesić, RS

• Challenge for pathologist S. Milenković, RS 9:20 Discussion

9:30 Cervical or endometrial adenocarcinoma E. Iljazović, BH 9:50 Discussion

10:00 Cervical adenocarcinoma: skipping the diagnosis E. Iljazović, BH 10:20 Discussion

10:30 fertility preservation in early cervical cancer: to whom it should be offered • A brief overview of fertility sparing options F. Peccatori, IT • Pathological indications for fertility sparing surgery S. Lax, AT 10:50 Discussion

11:00 Coffee break

11:30 Management of locally advanced cervical cancer C. Sessa, CH 11:50 Discussion

12:00 Tips and tricks: Selected cases presented by participants and discussed with the faculty

12:30 Lunch

ENDOMETRIAL CANCER

14:30 Risk factors and pathogenesis of endometrial cancer in young women V. Kesić, RS 14:50 Discussion

15:00 Benign endometrial proliferations mimicking malignancies: a review of problematic entities in small biopsy specimen X. Matias-Guiu, ES 15:20 Discussion


R W

D • V

• S D

C E D

C E D

f • F • D

C

M C D

T

L

R V D

B a D

15:30 The role of Pathology in conservative management of atypical hyperplasia and early endometrial cancer • View of clinician V. Kesić, RS • View of pathologist S. Lax, AT 15:50 Discussion

16:00 Risk groups of endometrial cancer - does pathology influence the treatment? X. Matias-Guiu, ES 16:20 Discussion

16:30 Coffee break

17:00 Tips and tricks: Selected cases presented by participants and discussed with the faculty

19:00 Glass with the experts

20:00 Dinner

Thursday, 28 May OVARIAN CANCER

8:30 Borderline tumors: a never ending challenge • View of clinician F. Peccatori, IT • View of pathologist S. Carinelli, ITD 8:50 Discussion

9:00 Tumor type: challenge of morphology S. Tomić, HR 9:20 Discussion

9:30 Role of immunohistochemistry in daily practice: take the best S. Carinelli, IT 9:50 Discussion

10:00 Management of ovarian cancer: challenge and future directions? C. Sessa, CH 10:20 Discussion

10:30 Coffee break

11:00 Tips and tricks: Selected cases presented by participants and discussed with the faculty 12:30 Summary of the course

13:00 Buffet lunch and farewell


GENERAL INfORMATION

PARTICIPATIONAdmittance to the course is by competitive application. The successful applicants are granted free registration and full board. Non-local participants will be offered accommodation in Tuzla for the period 26-28 May 2020. Travel will be covered by the participants.Applications made as a team from the same institute i.e. (at least two members: pathologist and surgeon, pathologist and medical oncologist, pathologist and radiotherapist etc) to promote multidiciplinarity are welcome. Full participation is compulsory throughout the course for all participants. The course will be taught entirely in English and fluency in English is necessary for admission.Priority will be given to candidates practicing in Eastern Europe and Balkan region countries.

hOW TO APPLyThose interested should apply online at www.eso.net, providing

• Letter describing motivation for attending the course - please mention here if you are participating with a team member and add their name

• Short CV – complete template provided • Supporting letter from Head of Department/Mentor• Abstract with proposed presentation of a pathological case relating to one of the main

themes of the course:

• Cervix • Endometrial• Ovary

The abstract should be presented in the form of a grand-round discussion or brief casepresentation and describe:

• Diagnostic considerations• Treatment • Outcome (follow-up)• Up to three questions that the author proposes for discussion by the faculty and

participants

APPLICATION DEADLINE: 31 JANUARy 2020Information and online application are available at www.eso.net

ORGANISING SECRETARIAT

European School of OncologyPiazza Indipendenza 2 | 6500 Bellinzona | SwitzerlandDolores Knupfer and Laura Richetti Ph: +41 91 820 0952 | Fax: +41 91 820 0953 E-mail: [email protected] - [email protected]


eso course on 26-28 may 2020 pathology of tuzla … · 2019. 10. 30. · courses and seminars 26-28...

Documents